{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:45:14Z","timestamp":1793169914651,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017128","name":"Natural Science Foundation for Distinguished Young Scholars of Anhui Province","doi-asserted-by":"publisher","award":["1808085J28"],"award-info":[{"award-number":["1808085J28"]}],"id":[{"id":"10.13039\/100017128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81202541"],"award-info":[{"award-number":["81202541"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973314"],"award-info":[{"award-number":["81973314"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973332"],"award-info":[{"award-number":["81973332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2021xkj039"],"award-info":[{"award-number":["2021xkj039"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017668","name":"Anhui Provincial Key Research and Development Plan","doi-asserted-by":"publisher","award":["2022e07020042"],"award-info":[{"award-number":["2022e07020042"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.biopha.2022.113997","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:18:16Z","timestamp":1668471496000},"page":"113997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation"],"prefix":"10.1016","volume":"157","author":[{"given":"Juan","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunru","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paipai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenduo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113997_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/intimm\/dxt075","article-title":"Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis","volume":"26","author":"Abd-Allah","year":"2014","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2022.113997_bib2","article-title":"Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region","volume":"15","author":"Sun","year":"2021","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.biopha.2022.113997_bib3","unstructured":"Y. Chang,X.. Jia,F.. Wei CP-25, a novel compound, protects against autoimmune arthritis by modulating immune 12;15:100240."},{"key":"10.1016\/j.biopha.2022.113997_bib4","doi-asserted-by":"crossref","unstructured":"S.A. Bakheet,M.A.. Ansari,A.. Nadeem. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17\/Treg cell balance. Cell Signal. 109395.","DOI":"10.1016\/j.cellsig.2019.109395"},{"key":"10.1016\/j.biopha.2022.113997_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41423-021-00644-5","article-title":"Local and systemic effects of IL-17 in joint inflammation: a historical perspective from discovery to targeting","volume":"18","author":"Miossec","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2022.113997_bib6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41401-019-0337-2","article-title":"IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-kappaB signaling pathways","volume":"41","author":"Han,X","year":"2020","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2022.113997_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.biopha.2022.113997_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102429","article-title":"Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies","volume":"19","author":"Ruiz de Morales","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2022.113997_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2018.12.024","article-title":"Inflammasome activation and Th17 responses","volume":"107","author":"Deng","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2022.113997_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10787-020-00757-9","article-title":"Current and novel therapeutic targets in the treatment of rheumatoid arthritis","volume":"28","author":"George","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2022.113997_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.imbio.2016.10.001","article-title":"STA-21, a STAT-3 inhibitor, attenuates the development and progression of inflammation in collagen antibody-induced arthritis","volume":"222","author":"Ahmad","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2022.113997_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113997_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bcpt.12164","article-title":"Therapeutic targeting of the Jak\/STAT pathway","volume":"114","author":"Aittomaki","year":"2014","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.biopha.2022.113997_bib14","doi-asserted-by":"crossref","unstructured":"G.E. Fragoulis,I.B. McInnes\uff0cS.. Siebert, 2019.JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis. Rheumatology (Oxford). 58.(2019):i43-i54:doi:10.1093\/rheumatology\/key276.","DOI":"10.1093\/rheumatology\/key276"},{"key":"10.1016\/j.biopha.2022.113997_bib15","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1182\/blood-2006-04-017434","article-title":"Loss of SHP1 enhances JAK3\/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma","volume":"108","author":"Han","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113997_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni0808-835","article-title":"Arrestin NK cell cytotoxicity","volume":"9","author":"Bryceson","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.113997_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.micinf.2009.04.007","article-title":"Signal transduction and Th17 cell differentiation","volume":"11","author":"O'Shea","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.biopha.2022.113997_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.022281","article-title":"Inhibiting Insulin-Mediated beta2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.113997_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1398-9995.2010.02352.x","article-title":"Conversion of Th17-type into Th2-type inflammation by acetyl salicylic acid via the adenosine and uric acid pathway in the lung","volume":"65","author":"Moon","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.biopha.2022.113997_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112482","article-title":"Down-regulation of A3AR signaling by IL-6-induced GRK2 activation contributes to Th17 cell differentiation","volume":"399","author":"Hu","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2022.113997_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/CS20191032","article-title":"CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4\/AC\/cAMP\/PKA-mediated GRK2 translocation","volume":"134","author":"Han","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2022.113997_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108909","article-title":"Ginsenoside metabolite compound-K regulates macrophage function through inhibition of beta-arrestin2","volume":"115","author":"Wang","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2022.113997_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41401-020-00507-1","article-title":"Deficiency of beta-arrestin2 exacerbates inflammatory arthritis by facilitating plasma cell formation","volume":"42","author":"Zhou","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2022.113997_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10787-019-00608-2","article-title":"Ginsenoside compound-K inhibits the activity of B cells through inducing IgD-B cell receptor endocytosis in mice with collagen-induced arthritis","volume":"27","author":"Zhang","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2022.113997_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/aps.2014.7","article-title":"Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis","volume":"35","author":"Liu","year":"2014","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2022.113997_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10456-015-9470-9","article-title":"An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models","volume":"18","author":"Fagiani","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2022.113997_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108796","article-title":"BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway","volume":"114","author":"Hu","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2022.113997_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12885-019-5659-4","article-title":"Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients","volume":"19","author":"Zheng","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2022.113997_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fphar.2018.00563","article-title":"A modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice","volume":"9","author":"Chen","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2022.113997_bib30","doi-asserted-by":"crossref","first-page":"45364","DOI":"10.1038\/srep45364","article-title":"Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113997_bib31","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1091\/mbc.e11-04-0373","article-title":"The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin\/GHSR1a system","volume":"22","author":"Lodeiro","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2022.113997_bib32","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ni.1635","article-title":"An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells","volume":"9","author":"Yu","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.113997_bib33","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10067-016-3202-4","article-title":"The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis","volume":"35","author":"Fishman","year":"2016","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.biopha.2022.113997_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjp.0702081","article-title":"Enhanced expression of G protein-coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist-induced desensitization","volume":"125","author":"Mundell","year":"1998","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2022.113997_bib35","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.biopha.2018.12.040","article-title":"CP-25 combined with MTX\/ LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation","volume":"110","author":"Yang","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2022.113997_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molimm.2016.08.017","article-title":"The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3(+) regulatory T cells during pathogenesis of rheumatoid arthritis","volume":"78","author":"Ahmad","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2022.113997_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.intimp.2014.01.005","article-title":"Attenuation of the progression of adjuvant-induced arthritis by 3-aminobenzamide treatment","volume":"19","author":"Ahmad","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2022.113997_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cyto.2014.04.006","article-title":"Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model","volume":"68","author":"Ahmad","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2022.113997_bib39","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1002\/jmv.26654","article-title":"Defining IL-6 levels in healthy individuals: a meta-analysis","volume":"93","author":"Said","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2022.113997_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/pr.113.008540","article-title":"The A3 adenosine receptor: history and perspectives","volume":"67","author":"Borea","year":"2015","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2022.113997_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2019.08.009","article-title":"ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis","volume":"214","author":"da Silva","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2022.113997_bib42","doi-asserted-by":"crossref","first-page":"2310970","DOI":"10.1155\/2018\/2310970","article-title":"Inhibition of IL-17 and IL-23 in human keratinocytes by the A3 adenosine receptor agonist piclidenoson","volume":"2018","author":"Cohen","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2022.113997_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphar.2019.00112","article-title":"G Protein-coupled receptor kinase 2 (GRK2) as a potential therapeutic target in cardiovascular and metabolic diseases","volume":"10","author":"Murga","year":"2019","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2022.113997_bib44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.apsb.2021.01.015","article-title":"Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113997_bib45","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s41401-018-0196-2","article-title":"CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis","volume":"40","author":"Jia","year":"2019","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2022.113997_bib46","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","article-title":"The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis","volume":"74","author":"Boyle","year":"2015","journal-title":"Ann. Rheum. Dis."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222013865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222013865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:16:54Z","timestamp":1778242614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222013865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":46,"alternative-id":["S0753332222013865"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113997","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113997"}}